Plus Therapeutics (STU:XMP0) YoY EPS Growth : 64.46% (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Plus Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Plus Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2024 was 64.46%.

Plus Therapeutics's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €-0.33.

Plus Therapeutics YoY EPS Growth Historical Data

The historical data trend for Plus Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plus Therapeutics YoY EPS Growth Chart

Plus Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

90.28

79.43

35.75

25.81

64.43

Plus Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY EPS Growth	Get a 7-Day Free Trial															67.45	71.18	64.30	-21.10	64.46

Plus Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Plus Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-3.888	-	-10.932)	/	\| -10.932 \|
=	64.43 %

Plus Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY EPS Growth (Q: Sep. 2024 )
=	(Earnings per Share (Diluted) (Q: Sep. 2024 )	-	Earnings per Share (Diluted) (Q: Sep. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Sep. 2023 )) \|
=	(-0.333	-	-0.937)	/	\| -0.937 \|
=	64.46 %

Plus Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Plus Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Plus Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Plus Therapeutics Inc (STU:XMP0) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

PSTV:USA XMP0:Germany

Address

4200 Marathon Boulevard, Suite 200, Austin, TX, USA, 78756

Website

https://www.plustherapeutics.com

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Plus Therapeutics Headlines

No Headlines